Fig. 5.

Individual-based model projections of P. vivax transmission in New Ireland under a range of intervention scenarios. Model predictions are based on the median of 100 stochastic simulations. a LLIN campaign every 3 years at 80% coverage. b LLIN campaigns plus introduction of tafenoquine (TQ) into first-line treatment regimen from 2020 such that 50% of clinical cases are treated. c LLIN campaigns plus mass drug administration (MDA) with tafenoquine at 80% coverage in 2020. d LLIN campaigns with TQ incorporated in first-line treatment regimen and TQ MDA. e Estimated clinical cases per 1000 person years for the period 2020–2022 under the intervention scenarios considered. f Estimated number of TQ doses per person over the period 2020–2022